Ruud Van der Velden
Ruud van der Velden represents companies in patent litigation against infringers and defends them against actions of others. He enjoys working with companies on their IP strategies, as he recognises that the development of a good IP strategy is essential to success in court and in the market.
Ruud represents companies in patent and trade secret litigation in various technological fields, with a particular focus on life sciences and high tech industries. He combines his knowledge of patent law with an understanding of the market and regulatory issues. He has specific expertise in obtaining evidence. In one particular case, he was able to obtain access to evidence seized in the Netherlands relating to patent infringements abroad even though no patent was in force in the Netherlands.
Ruud started his career at Hogan Lovells in 2005. In the first patent case he ever litigated, he was able to obtain a cross-border injunction for his client even though such cross-border injunctions were considered no longer possible at the time. In 2008, Ruud received the Gouden Zandloper award for Best Young Lawyer in the Netherlands. Three years later, he received the VIE Award of the Dutch AIPPI Group for a publication on obtaining evidence of patent infringement. Ruud is recommended by the relevant legal directories, including Chambers Global (2017) which states: "Ruud van der Velden is recommended as a "very strong patent litigator" who is building an impressive practice. Clients describe him as "very detail-oriented and proactive" and praise his independence."
"he is in hot demand as a counsellor and litigator, given his specialist knowledge of cross-border injunctions and evidentiary seizures"
"Ruud van der Velden is recommended as a "very strong patent litigator" who is building an impressive practice. Clients describe him as "very detail-oriented and proactive" and praise his independence."
Areas of Focus
Obtaining an injunction for Merck in patent infringement proceedings against Mylan relating to a medical use patent for Finasteride 1 mg
Representing HTC in patent infringement proceedings initiated by Nokia, which led to a settlement between the parties.
Seizing and obtaining evidence for Solvay in a Dutch warehouse in relation to patent infringement abroad by Neo (in absence of a Dutch patent).
Defending OrbusNeich against patent infringement claims relating to its rapid exchange catheter, resulting in revocation of Boston Scientific's patent
Representing Du Pont in the successful defence of the first paediatric SPC extension in the Netherlands
Representing a Honeywell subsidiary in trade secret proceedings leading to the termination of the defendant's business activities.